PFM Health Sciences’s Charles Schwab SCHW Stock Holding History

PFM Health Sciences’s Portfolio SCHW Stock Details SCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,033,855	Closed	-$42.2M	–	108
2017 Q1	$42.2M	Buy	1,033,855 +510,467	+98%	+$21.1M	1.06%	40
2016 Q4	$20.7M	Buy	+523,388	New	+$18.7M	0.58%	57
2016 Q1	–	Sell	-2,779,577	Closed	-$91.5M	–	92
2015 Q4	$91.5M	Buy	+2,779,577	New	+$88M	2.78%	11
2015 Q2	–	Sell	-1,004,371	Closed	-$30.6M	–	106
2015 Q1	$30.6M	Buy	+1,004,371	New	+$29.1M	0.84%	43
2014 Q4	–	Sell	-2,847,805	Closed	-$83.7M	–	97
2014 Q3	$83.7M	Buy	2,847,805 +914,769	+47%	+$25.9M	1.93%	24
2014 Q2	$52.1M	Sell	1,933,036 -3,058,222	-61%	-$80.3M	1.04%	33
2014 Q1	$136M	Buy	+4,991,258	New	+$130M	2.47%	12
2013 Q4	–	Sell	-2,125,377	Closed	-$44.9M	–	72
2013 Q3	$44.9M	Buy	+2,125,377	New	+$46.2M	1.08%	27

Other funds holding SCHW

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PFM Health Sciences's SCHW Position: Q2 2017 in Review

PFM Health Sciences sold out of Charles Schwab (SCHW) in Q2 2017, closing a stake of 1,033,855 shares — an estimated $42.2M sold.

PFM Health Sciences first reported a position in SCHW in Q3 2013 and held it in 8 quarters. The position peaked at $136M in Q1 2014. 900 funds tracked by Wall St. Rank hold SCHW as of Q2 2017.

PFM Health Sciences reported no remaining Charles Schwab position as of Q2 2017 after selling out during the quarter.
PFM Health Sciences sold 1,033,855 Charles Schwab shares in Q2 2017, an estimated $42.2M.
PFM Health Sciences first reported a position in Charles Schwab in Q3 2013 and held it in 8 quarters.
PFM Health Sciences's Charles Schwab position peaked at $136M in Q1 2014.
900 funds tracked by Wall St. Rank held Charles Schwab as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.